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E-mail address: baudin@embl.de (F. Baudin).Many viral mRNAs contain a 50-UTR RNA element called internal ribosome-entry site (IRES), which
bypasses the requirement of some canonical initiation factors allowing cap-independent transla-
tion. The IRES of hepatitis-C virus drives translation by directly recruiting 40S ribosomal subunits
and binds to eIF3 which plays a critical role in both cap-dependent and cap-independent translation.
However, the molecular basis for eIF3 activity in either case remains enigmatic. Here we report that
subunit b of the eIF3 complex directly binds to HCV IRES domain III via its N-terminal-RRM. Because
eIF3b was previously shown to be involved in eIF3j binding, biological implications are discussed.
 2008 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
In eukaryotic organisms, translation of most messenger RNAs
requires numerous eukaryotic initiation factors (eIFs) that stimu-
late and regulate formation of an elongation competent ribosome
at the translation initiation codon. This includes recognition of
the m7G-structure, recruitment of the 40S ribosomal subunit
charged with Met-tRNAiMet, scanning of the 50 untranslated region
(UTR) and start codon recognition ﬁnally resulting in subunit join-
ing and translation of the mRNA. Initiation of HCV protein synthe-
sis does not require the recognition of an m7G-structure. Instead,
the HCV RNA genome contains a conserved and well-deﬁned struc-
ture present in its 50-UTR which acts as an internal ribosome-entry
site (IRES) [1]. Brieﬂy, the small ribosomal subunit (40S) and
eukaryotic initiation factor eIF3 bind speciﬁcally to the HCV IRES,
allowing direct recognition of the start codon present in the 50-
UTR of the viral mRNAs. Ribosomal 40S subunits bind to the HCV
IRES with a very high afﬁnity (KD1.9 nM) in the vicinity of the ini-
tiation codon [2]. So far, eight of 40S ribosomal subunit proteins
have been suggested to interact with the HCV IRES [3,4]. eIF3 is a
multiprotein complex (ca 800 kDa) containing 13 subunits inchemical Societies. Published by Emammals (named eIF3a to eIF3m; nomenclature reviewed in [5])
controlling the assembly of 40S ribosomal subunits on mRNAs
bearing either an IRES or a 50cap structure. eIF3 was shown to pre-
vent premature association of the 40S and 60S ribosomal subunits,
it interacts with other initiation factors involved in start codon rec-
ognition, and helps assemble active ribosomes. Despite its impor-
tance in both cellular and viral protein synthesis, the structural
basis for eIF3 activities and interactions with the translational
machinery are only poorly understood. The recent cryo-electron
microscopy reconstruction of human eIF3 at 30 Å resolution re-
vealed a ﬁve-lobed architecture [6]. eIF3 was shown to speciﬁcally
associate with the apical half of domain III of the HCV IRES [7,8].
Six of its subunits (eIF3a, b, c, d, f and g) have been proposed to ex-
hibit RNA-binding activity but none of them has been character-
ized individually. Among the eIF3 subunits, eIF3b is considered
to be the major scaffolding subunit, interacting with eIF3a, g, i,
and j [9,10]. The human eIF3b subunit is an 814 amino acid residue
protein, whose primary sequence reveals only one identiﬁable do-
main, an RNA recognition motif (RRM), located in its N-terminal
moiety. In the present paper, using NMR spectroscopy we show
that subunit eIF3b is able to bind directly to domain III of the IRES
of HCV RNA through its N-terminal RRM. Because eIF3b was
previously shown to be involved in eIF3j binding [11], biological
implications are discussed.lsevier B.V. All rights reserved.
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2.1. Plasmid constructs and protein puriﬁcation
The DNA fragments encoding full-length eIF3b, the RRM of
eIF3b (aa 185–268) and the RRM of eIF3g (aa 227–321) were
PCR-ampliﬁed from cDNA libraries (ImaGenes) and subcloned into
a pET28a-TEV vector for the expression of His-tagged fusion pro-
teins. Proteins were expressed in E. coli BL21 (DE3) and puriﬁed
using a His-Select Cobalt column (SIGMA). Double labeled 13C,
15N-RRM was produced in M9 minimum media and puriﬁed
according to standard protocols. Eluted fractions were pooled
and concentrated prior to size exclusion chromatography, then
analyzed by SDS–PAGE, see Supplementary Data.
The eIF3 complex was puriﬁed from rabbit reticulocyte lysate
(RRL, Green Hectares) essentially as described in [12]), see Sup-
plementary Data.
Anti eIF3b-RRM and anti eIF3g-RRM monoclonal antibodies
were produced using standard techniques (rProteinA sepharose,
GE Healthcare).
2.2. RNA synthesis by in vitro transcription
RNAs comprising the IRES elements of HCV RNA were tran-
scribed in vitro from linearized plasmids using T7 RNA polymerase.
Brieﬂy, HCV IRES element containing plasmid templates were lin-
earized with HindIII and puriﬁed by phenol/ether extraction fol-
lowed by ethanol precipitation. Transcription was performed in
standard buffer using [a-32P]-UTP and labeled RNAs were then
puriﬁed by PAGE.
2.3. Binding reactions and ﬁlter-binding-assay
Radioactive RNAwas ﬁrst renatured by heating in water at 95 C
for 1 min, cooled down to 25 C and incubated in buffer A (20 mM
Tris–HCl pH 7.5, 200 mM KCl, 2.5 mM MgCl2, 1 mM DTT). ProteinsFig. 1. eIF3 complex, eIF3b and eIF3b-RRM bind to HCV IRES RNA. (A–D) Binding kinetics
full-length HCV IRES RNA (d) or domain III only (O) using FBA. (A) eIF3 complex. (B
recombinant domain. (E) Competitive binding assays. Labeled HCV IRES RNA was ﬁrst
(4.1011–4.106 M) of cold HCV IRES RNA competitor. Results are expressed as percentag
domains II, III and IV was incubated with eIF3 (1 nM–1 lM) and loaded onto a native 6were serially diluted (from 100 lM to 0.1 nM) in a ﬁnal volume of
180 ll, followed by addition of 20 ll of renatured 32P-labeled
RNA. After incubation at 37 C, the reactions were ﬁltered through
a nitrocellulose ﬁlter and the radioactivity counted. For each series,
a blank reaction and total RNA input were determined. Because the
amount of labeled RNA is negligible, an apparent dissociation coef-
ﬁcient (KD) can be estimated from the concentration value at 50%
RNA retention. The interference of speciﬁc antibodies with complex
formation was tested using monoclonal antibodies directed against
the eIF3b- or eIF3g-RRMs or against the His-tag. HCV IRES RNA was
ﬁrst prebound to eIF3b-RRM, then incubated with MABs for 30 min
at 37 C using a stoichiometric ratio (1:1). For competition experi-
ments, P32-labeledHCV IRES RNAwas ﬁrst bound to 20 lMproteins,
then increasing concentrations of unlabeled competitor RNA
(4.1011–4.106 M) were used to challenge the complex. Reported
values are the average of at least three independent experiments.
2.4. NMR studies
The interaction of RRM with IRES was followed by titration of a
1 mM protein solution with a 0.3 mM solution of IRES RNA, both in
buffer A at 25 C. Chemical shift perturbations were followed by
acquiring TROSY 1H-15N correlation spectra with an 800 MHz spec-
trometer equipped with a cryogenic probe. Spectra were recorded
for the free protein and for protein/ RNA (ratios of 4/1 and 1/1.25).
Chemical shift perturbations were calculated as a weighed distance
on the 1H–15N plane between the signals for the free protein and
those of the protein in the presence of excess IRES-RNA, see Sup-
plementary Data.
3. Results and discussion
3.1. eIF3 multisubunit complex binds to the IRES element of HCV RNA
Tomeasure the afﬁnity of eIF3 complex to the IRES present in the
HCV RNA, radiolabeled IRES RNA was incubated with increasingof rabbit eIF3 complex, human eIF3b, human eIF3b-RRM and human eIF3g-RRM to
) eIF3b recombinant protein. (C) eIF3b-RRM recombinant domain. (D) eIF3g-RRM
complexed to 2.105 M of eIF3b-RRM, before addition of increasing concentrations
e of RNA bound. (F) eIF3 binds to HCV IRES RNA in EMSA. Labeled RNA comprising
% polyacrylamide gel.
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resulting complexes were quantiﬁed by ﬁlter-binding-assays
(FBA, Fig. 1). We could measured an apparent equilibrium dissocia-
tion constant (KD) of 5 nM for the binding of eIF3 complex to the
IRES (Fig. 1A). These results were conﬁrmed by an electrophoretic
mobility shift assay (EMSA, Fig. 1F). At 1 nM eIF3 complex concen-
tration, a certain proportion of HCV IRES is already retained in the
well due to the high molecular weight of the protein complex.
The afﬁnity of eIF3 complex for IRES HCV RNAwas already reported
in the literature to be 35 nM [2]. The discrepancy between both
results (5 nM/35 nM) is certainly not signiﬁcant since the estima-
tion of the concentration of the eIF3 is achieved on the whole com-
plex and is probably subjected to variations.
3.2. Isolated subunit b of the eIF3 complex binds to the IRES of HCV
RNA
In order to test whether subunit eIF3b binds to the IRES ele-
ment, we expressed and puriﬁed human eIF3b. 1D NMR and CD
spectra ( Supplemental Fig. S4) were recorded to ensure proper
folding. Using the same experiments as described above (Fig. 1B),
we determined a KD of 106 M between eIF3b and HCV IRES RNA
(more than 2.5 log above the KD obtained for the eIF3 multicom-
plex). This drop of afﬁnity is predictable considering that eIF3b is
not the only subunit involved in the RNA binding. Although sub-Domain : dIII Domain : dIDomain : dIIDomain : dII, III,
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Fig. 3. eIF3b-RRM binds to domain III of HCV RNA. (A) Molecular dissection of HCV IRES-R
domain III (subdomains abcdef, nt 120–332), domain IV (nt 332–370). (B) Binding kinetic
(d): domains II, III, and IV, (N): domain II, (s): domain III, (4): domain IV.
Fig. 2. Speciﬁc monoclonal antibodies disrupt the HCV/eIF3b-RRM complex.
2.105 M of eIF3b-RRM was incubated with increasing concentrations of speciﬁc
MAbs aeIF3b-RRM (or aeIF3g-RRM (d) or a6xHis (N) prior addition of 32P-labeled
HCV full-length RNA. Results are expressed as percentage of RNA bound.units a, d and f of eIF3 were clearly involved in RNA interaction
[7], involvement of subunit b was not clearly established [8,13].
3.3. N-terminal recognition motif of eIF3b binds to HCV IRES RNA
Since the N-terminus of eIF3b contains a RNA recognition motif
(RRM), between aa 185 and 268 – a sequence often mediating pro-
tein–RNA interactions – we tested if this motif was sufﬁcient for
binding to the IRES element. As a control, the RRM of eIF3g (aa
239–317) was used. FBA revealed a KD of approx. 106 M for the
eIF3b-RRM/HCV IRES complex similar to the one measured for
the full-length protein (compare Fig. 1B and C). In contrast, the
RRM motif derived from eIF3g did not signiﬁcantly bind to the
RNA (Fig. 1D). This result suggests that the RRM motif present in
eIF3b is the responsible RNA-binding element. To investigate the
stability of the IRES/eIF3b-RRM complex, we performed competi-
tion experiments (Fig. 1E). Labeled IRES RNA was ﬁrst bound to a
constant amount of eIF3b-RRM (2.105 M) resulting in complete
incorporation of the RNA into the eIF3b-RRM/IRES RNA complex.
This complex was then challenged with increasing concentrations
of unlabeled HCV IRES RNA (ranging from 4.1011 M to 4.106 M,
Fig. 3) conﬁrming the previously determined KD (compare Fig. 1C
and E). Taken together these results show that the RRM motif of
eIF3b is sufﬁcient for mediating binding to the IRES element of
HCV RNA.
To further characterize the speciﬁcity of the binding of the IRES
to the RRM of eIF3b, we performed FBA experiments in the pres-
ence of increasing concentrations (from 3.107 M to 3.105 M) of
monoclonal antibodies (MABs) raised against the RRM of either
eIF3b or eIF3g or raised against the His-Tag (Fig. 2). Whereas the
aeIF3g-RRM and a6xHis did not affect RNA binding to eIF3b-
RRM, the monoclonal aeIF3b-RRM antibody efﬁciently prevented
complex formation.
3.4. The RRM of eIF3b binds to domain III of the HCV IRES element
The secondary structure of HCV IRES RNA consists of four
domains named I–IV (Fig. 3A). The afﬁnity of eIF3, eIF3b and
eIF3b-RRM for these different domains was determined using
FBA as described above (Figs. 1A, B and 3B). eIF3 was able to bind
to domain III with an apparent KD of 5 nM, identical to full-length
IRES RNA (Fig. 1A). eIF3b and eIF3b-RRM were also able to associ-
ate with domain III as tightly as with the full-length IRES RNA
(KD = 2 lM), demonstrating that domain III is necessary and sufﬁ-
cient for eIF3b-RRM binding. eIF3b-RRM was not able to bind
either domain II or IV (Fig. 3B).V
70
NA: full-length domains II, III, IV (nt 39-370 of genotype 1b), domain II (nt 43–120),
s of puriﬁed protein eIF3b-RRM to HCV IRES-RNA domains by ﬁlter-binding-assays.
Fig. 4. Mapping eIF3b-RRM/HCV IRES RNA interaction site. (A) Bar graph of the weighed chemical shift differences observed between free eIF3b-RRM and eIF3b-RRM/HCV
IRES RNA in 1/1.25 ratio, plotted against the residue number. The two regions showing the largest perturbations upon interaction are indicated. Weighed chemical shift
differences were calculated for each signal as follows: Ddweighed = [(Dd1H)2 + (A515N/6)2]1/2. (B) Surface representation of eIF3b-RRM showing the regions of interaction
with IRES as determined by NMR titration. Residues having a ppm >0.1 are painted in red, those between 0.06 and 0.1 in orange. (C) Surface potential of eIF3b-RRM. The
positively charged residues are indicated in blue and the negatively charged residues in red. Surface area on the opposite side is shown beside. Involved residues in RNA
interaction are visible through semi-transparent map. The run was carried out using the PDB structure of eIF3b-RRM using Pymol. (D) Surface representation of eIF3b-RRM
showing aa involved in eIF3j-RRM binding (results adapted from Ref. [11]. Orientation is the same as in (B) and (C). (E) Interacting residues between eIF3b-RRM and HCV IRES-
RNA are reported on the primary sequence, using the same color code as in (B). On top of the sequence, the deﬁned secondary motifs of the MRR are shown. Stars indicate the
residues of eIF3b-RRM involved in eIF3j interaction [11].
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To identify the eIF3b-RRM residues involved in the interaction
with HCV IRES RNA, we performed NMR titration experiments.
Chemical shift variations were monitored using two-dimensional
1H–15N correlation spectra. Upon addition of increasing amounts
of unlabeled IRES RNA to 15N-labeled eIF3b-RRM, we could follow
the chemical shift perturbations. The most affected resonances
clustered in two regions, between N191 and G196 and between
K254 and T260 (Fig. 4A). The highest chemical shift variations
(above 0.1 ppm) were observed for residues Q194, K254, D256,
Q258, H259 and T260 (Fig. 4A). Except for residue Q194 located
in loop 1, all the residues are located in strands b4, b5 and loop5
(Fig. 4E). Moderate chemical shift variations (between 0.06 and
0.1 ppm) were observed for residues I187, N191, V192, G196,
H208, H209, K216, F261 and R262, located in RNP2 motif, helix
a1 and strand b5. Interestingly, all these residues are located on
a protruding region separating the negatively charged face from
the positively charged face of the RRM (Fig. 4C). This binding mode
is different from the consensus RNA-binding surface of RRMs,
encompassing the RNP1 and RNP2 motifs (Fig. 4E), but resembles
the one observed for PTB RRM3 (polypyrimidine tract binding pro-
tein) in complex with RNA, where loop ﬁve represents a crucial
interaction region for RNA binding (reviewed in [14]).
ElAntack et al. [11] previously showed that the RRM of eIF3b
binds to subunit eIF3j (KD of 20 lM). This interaction involves nine
residues, listed in Fig. 4E. Because four of them are also involved in
HCV RNA binding, we could think that both partners are exclusive.
We found a dissociation constant (KD) of 2 lM between RNA do-
main III and eIF3b-RRM, 10 times higher as the one estimated for
the eIF3b-RRM/eIF3j-RRM interaction, which would suggest that
the IRES element would be favoured (as opposed for eIF3j) in the
eIF3 complex binding. Human eIF3j was shown to be required forthe stable binding of eIF3 to 40S ribosomal subunit without other
initiation factors. eIF3j is located in the ribosomal decoding center,
regulating mRNA binding to the ribosome [15], thus playing an
important role in cap-dependent translation initiation. By directly
interacting with the RRM of eIF3b, the HCV IRES might inﬂuence
or even bypass the function of eIF3j that during cap-driven
translation initiation associates with the same binding region. Fur-
thermore, our data imply that the HCV IRES functionally compen-
sates the bridging function of eIF3j by independently recruiting the
40S ribosomal subunit and the eIF3 complex.
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